Structure-activity relationships of neuroactive steroids acting on the GABAA receptor

The term "neuroactive steroid" (NAS) refers to steroids which, independent of their origin, are capable of modifying neural activities. These steroids positively or negatively modulate the function of members of the ligand-gated ion channel superfamily. Those with positive allosteric actio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2009
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09298673_v16_n4_p455_Veleiro
http://hdl.handle.net/20.500.12110/paper_09298673_v16_n4_p455_Veleiro
Aporte de:
id paper:paper_09298673_v16_n4_p455_Veleiro
record_format dspace
spelling paper:paper_09298673_v16_n4_p455_Veleiro2023-06-08T15:52:27Z Structure-activity relationships of neuroactive steroids acting on the GABAA receptor Anticonvulsant GABAA receptor Neuroactive steroids Neurosteroids Structure-activity relationship 17 phenyl 5alpha androst 16 en 3alpha ol 17alpha aza d homosteroid derivative 17beta alkynyl derivative 17beta carbonitrile 2 isopropylmorpholine derivative 22 bromoalkynyl derivative 3alpha amino 5alpha pregan 20 one 3alpha hydroxy 3beta trifluoromethyl 19 nor 5beta pregnan 20 one 3alpha hydroxy 5alpha pregnan 20 one 3alpha,21 dihydroxy 5 alpha pregnan 20 one 3beta carboxamidomethyl 3beta hydroxymethyl 3beta methyl derivative 4 aminobutyric acid receptor alfaxalone alkynyl pregnanediol derivative allotetrahydrodeoxycorticosterone androsterone azasteroid derivative chlorine 36 eltanolone fluorinated steroid ganaxolone minaxolone oxetane derivative pregnanediol derivative steroid tertiary amine tetrahydrodeoxycorticosterone unclassified drug unindexed drug 4 aminobutyric acid A receptor steroid anticonvulsant activity anxiety disorder binding affinity binding site brain electrophysiology cerebellum clinical trial drug receptor binding drug synthesis drug targeting drug withdrawal epilepsy human insomnia membrane binding nonhuman pharmacophore protein expression protein targeting review structure activity relation structure analysis synaptic membrane synaptosome urticaria animal chemical structure chemistry physiology Animals Humans Molecular Structure Receptors, GABA-A Steroids Structure-Activity Relationship The term "neuroactive steroid" (NAS) refers to steroids which, independent of their origin, are capable of modifying neural activities. These steroids positively or negatively modulate the function of members of the ligand-gated ion channel superfamily. Those with positive allosteric actions on the γ-amino butyric acid type A receptor (GABAA receptor) have been shown to be potent anticonvulsants, anxiolytics, and antistress agents and to possess sedative, hypnotic, and anesthetic activities. New types of neuroactive steroids have been widely sought and structural modifications of the naturally occurring metabolites allopregnanolone, pregnanolone and allotetrahydrodeoxycorticosterone, have been examined in the light of the vast family of GABA receptor subtypes within the brain. Here we review the structure-activity relationship (SAR) of neuroactive steroid analogues obtained by modification of the steroid nucleus, including substitutions at the A, B, C, and D rings and the side chain, with emphasis on the different pharmacophores proposed. © 2009 Bentham Science Publishers Ltd. 2009 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09298673_v16_n4_p455_Veleiro http://hdl.handle.net/20.500.12110/paper_09298673_v16_n4_p455_Veleiro
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Anticonvulsant
GABAA receptor
Neuroactive steroids
Neurosteroids
Structure-activity relationship
17 phenyl 5alpha androst 16 en 3alpha ol
17alpha aza d homosteroid derivative
17beta alkynyl derivative
17beta carbonitrile
2 isopropylmorpholine derivative
22 bromoalkynyl derivative
3alpha amino 5alpha pregan 20 one
3alpha hydroxy 3beta trifluoromethyl 19 nor 5beta pregnan 20 one
3alpha hydroxy 5alpha pregnan 20 one
3alpha,21 dihydroxy 5 alpha pregnan 20 one
3beta carboxamidomethyl
3beta hydroxymethyl
3beta methyl derivative
4 aminobutyric acid receptor
alfaxalone
alkynyl pregnanediol derivative
allotetrahydrodeoxycorticosterone
androsterone
azasteroid derivative
chlorine 36
eltanolone
fluorinated steroid
ganaxolone
minaxolone
oxetane derivative
pregnanediol derivative
steroid
tertiary amine
tetrahydrodeoxycorticosterone
unclassified drug
unindexed drug
4 aminobutyric acid A receptor
steroid
anticonvulsant activity
anxiety disorder
binding affinity
binding site
brain electrophysiology
cerebellum
clinical trial
drug receptor binding
drug synthesis
drug targeting
drug withdrawal
epilepsy
human
insomnia
membrane binding
nonhuman
pharmacophore
protein expression
protein targeting
review
structure activity relation
structure analysis
synaptic membrane
synaptosome
urticaria
animal
chemical structure
chemistry
physiology
Animals
Humans
Molecular Structure
Receptors, GABA-A
Steroids
Structure-Activity Relationship
spellingShingle Anticonvulsant
GABAA receptor
Neuroactive steroids
Neurosteroids
Structure-activity relationship
17 phenyl 5alpha androst 16 en 3alpha ol
17alpha aza d homosteroid derivative
17beta alkynyl derivative
17beta carbonitrile
2 isopropylmorpholine derivative
22 bromoalkynyl derivative
3alpha amino 5alpha pregan 20 one
3alpha hydroxy 3beta trifluoromethyl 19 nor 5beta pregnan 20 one
3alpha hydroxy 5alpha pregnan 20 one
3alpha,21 dihydroxy 5 alpha pregnan 20 one
3beta carboxamidomethyl
3beta hydroxymethyl
3beta methyl derivative
4 aminobutyric acid receptor
alfaxalone
alkynyl pregnanediol derivative
allotetrahydrodeoxycorticosterone
androsterone
azasteroid derivative
chlorine 36
eltanolone
fluorinated steroid
ganaxolone
minaxolone
oxetane derivative
pregnanediol derivative
steroid
tertiary amine
tetrahydrodeoxycorticosterone
unclassified drug
unindexed drug
4 aminobutyric acid A receptor
steroid
anticonvulsant activity
anxiety disorder
binding affinity
binding site
brain electrophysiology
cerebellum
clinical trial
drug receptor binding
drug synthesis
drug targeting
drug withdrawal
epilepsy
human
insomnia
membrane binding
nonhuman
pharmacophore
protein expression
protein targeting
review
structure activity relation
structure analysis
synaptic membrane
synaptosome
urticaria
animal
chemical structure
chemistry
physiology
Animals
Humans
Molecular Structure
Receptors, GABA-A
Steroids
Structure-Activity Relationship
Structure-activity relationships of neuroactive steroids acting on the GABAA receptor
topic_facet Anticonvulsant
GABAA receptor
Neuroactive steroids
Neurosteroids
Structure-activity relationship
17 phenyl 5alpha androst 16 en 3alpha ol
17alpha aza d homosteroid derivative
17beta alkynyl derivative
17beta carbonitrile
2 isopropylmorpholine derivative
22 bromoalkynyl derivative
3alpha amino 5alpha pregan 20 one
3alpha hydroxy 3beta trifluoromethyl 19 nor 5beta pregnan 20 one
3alpha hydroxy 5alpha pregnan 20 one
3alpha,21 dihydroxy 5 alpha pregnan 20 one
3beta carboxamidomethyl
3beta hydroxymethyl
3beta methyl derivative
4 aminobutyric acid receptor
alfaxalone
alkynyl pregnanediol derivative
allotetrahydrodeoxycorticosterone
androsterone
azasteroid derivative
chlorine 36
eltanolone
fluorinated steroid
ganaxolone
minaxolone
oxetane derivative
pregnanediol derivative
steroid
tertiary amine
tetrahydrodeoxycorticosterone
unclassified drug
unindexed drug
4 aminobutyric acid A receptor
steroid
anticonvulsant activity
anxiety disorder
binding affinity
binding site
brain electrophysiology
cerebellum
clinical trial
drug receptor binding
drug synthesis
drug targeting
drug withdrawal
epilepsy
human
insomnia
membrane binding
nonhuman
pharmacophore
protein expression
protein targeting
review
structure activity relation
structure analysis
synaptic membrane
synaptosome
urticaria
animal
chemical structure
chemistry
physiology
Animals
Humans
Molecular Structure
Receptors, GABA-A
Steroids
Structure-Activity Relationship
description The term "neuroactive steroid" (NAS) refers to steroids which, independent of their origin, are capable of modifying neural activities. These steroids positively or negatively modulate the function of members of the ligand-gated ion channel superfamily. Those with positive allosteric actions on the γ-amino butyric acid type A receptor (GABAA receptor) have been shown to be potent anticonvulsants, anxiolytics, and antistress agents and to possess sedative, hypnotic, and anesthetic activities. New types of neuroactive steroids have been widely sought and structural modifications of the naturally occurring metabolites allopregnanolone, pregnanolone and allotetrahydrodeoxycorticosterone, have been examined in the light of the vast family of GABA receptor subtypes within the brain. Here we review the structure-activity relationship (SAR) of neuroactive steroid analogues obtained by modification of the steroid nucleus, including substitutions at the A, B, C, and D rings and the side chain, with emphasis on the different pharmacophores proposed. © 2009 Bentham Science Publishers Ltd.
title Structure-activity relationships of neuroactive steroids acting on the GABAA receptor
title_short Structure-activity relationships of neuroactive steroids acting on the GABAA receptor
title_full Structure-activity relationships of neuroactive steroids acting on the GABAA receptor
title_fullStr Structure-activity relationships of neuroactive steroids acting on the GABAA receptor
title_full_unstemmed Structure-activity relationships of neuroactive steroids acting on the GABAA receptor
title_sort structure-activity relationships of neuroactive steroids acting on the gabaa receptor
publishDate 2009
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09298673_v16_n4_p455_Veleiro
http://hdl.handle.net/20.500.12110/paper_09298673_v16_n4_p455_Veleiro
_version_ 1768545564459270144